Menopause
Conditions
Interventions
A randomized and controlled clinical trial will be developed to evaluate the effectiveness of aromatherapy with Lippia alba Mill essential oil. N.E. Brown (lemon balm) on climacteric symptoms in women
b) Pittsburgh Sleep Quality Index, version for use in Brazil (PSQI-BR), which assesses sleep quality during the previous month
c) Blatt-Kupperman Menopausal Index (IMBK), which assesses the intensity of climacteric symptoms. It is expected that the aromatherapy intervention with Lippia alba essential oil will show a positive
Sponsors
Susy Maria Feitosa de Melo Rabelo
Universidade Estadual do Ceará
Eligibility
Sex/Gender
Female
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: Interest in participating in the study; age between 40 and 65 years; presence of one or more climacteric symptoms, reported from the Blatt and Kupperman Menopausal Index and with moderate to intense intensity; Menopause occurred no more than 5 years ago; Preserved cognitive function, assessed using the Mini Mental State Examination.
Exclusion criteria
Exclusion criteria: Women who have any speech articulation or hearing problems that prevent them from responding to the research instruments and participating in the intervention; Presence of dermatological lesions or considerable deformities in the nose, in addition to already recognized anosmia; Women who have undergone aromatherapy treatment or other PICS in the last month; Women using anxiolytic substances in the last month, such as: benzodiazepines, antihistamines, hypnotics, sedatives, antidepressants, antipsychotics, stimulants and corticosteroids; Women using hormone replacement therapy (HRT) in the last 3 months prior to the intervention; Previous clinical diagnosis of chronic diseases, such as: diabetes mellitus, systemic arterial hypertension, cardiovascular diseases, cancer, seizures, epilepsy and so on, decompensated; Women using antithrombotic medication, as drug interactions with Lippia alba are known; Recognized hypersensitivity after using Lippia alba in other formulations (teas, infusions, creams, lotions, shampoos, etc.); Users of Lippia alba essential oil.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be the presence and intensity of climacteric symptoms, measured by Blatt-Kupperman Menopausal Index (BKMI). It is expected that after 6 weeks of aromatherapy, women in the intervention group will show an improvement of 20% to 30% in the rates of climacteric symptoms, compared to the initial rates and the control group. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary or predictive variable will be: sleep, measured by Pittsburgh Sleep Quality Index (PSQI-BR). | — |
Countries
Brazil
Contacts
Public ContactSusy Maria Feitosa de Rabelo
Universidade Estadual do Ceará
Outcome results
None listed